(Q37787267)

23 August 2017

Mesenchymal stem cells: biological properties and clinical applications (English)

1 reference

23 August 2017

mesenchymal stem cell

1 reference

Agustín G Zapata

3

1 reference

ORCID Public Data File 2021

author name string

Ignacio García-Gómez

1

1 reference

23 August 2017

Gema Elvira

2

1 reference

23 August 2017

María L Lamana

4

1 reference

23 August 2017

Manuel Ramírez

5

1 reference

23 August 2017

Javier García Castro

6

1 reference

23 August 2017

Mariano García Arranz

7

1 reference

23 August 2017

Angeles Vicente

8

1 reference

23 August 2017

Juan Bueren

9

1 reference

23 August 2017

Damián García-Olmo

10

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

Expert Opinion on Biological Therapy

23 August 2017

1 reference

23 August 2017

10

1 reference

23 August 2017

10

1 reference

23 August 2017

1453-1468

1 reference

23 August 2017

Mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal progenitor cells in human umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Human adipose tissue is a source of multipotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

RETRACTED: Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

A perivascular origin for mesenchymal stem cells in multiple human organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Neuroepithelial cells supply an initial transient wave of MSC differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Defining stem and progenitor cells within adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stem cells stimulate antibody secretion in human B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Interactions between human mesenchymal stem cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Immunomodulatory effects of fetal and adult mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Toll-like receptors and their ligands control mesenchymal stem cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

How I treat refractory acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

The global burden of diabetic foot disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

21 January 2018

Cutaneous wound healing

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stem cell therapy for nonhealing cutaneous wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Wound therapy by marrow mesenchymal cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

A classification of fistula-in-ano

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Practice parameters for the treatment of perianal abscess and fistula-in-ano (revised).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Infliximab maintenance therapy for fistulizing Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Adaptive mechanisms to oxidative stress during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Interphase FISH demonstrates that human adipose stromal cells maintain a high level of genomic stability in long-term culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Biological characterization of long-term cultured human mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

New link in a web of human genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.519333

Spontaneous human adult stem cell transformation.

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-04-4194

Identifiers

DOI

10.1517/14712598.2010.519333

1 reference

23 August 2017

1 reference